Ingredient Access Restrictions in Competition Law

1. Introduction

Ingredient Access Restrictions arise when a dominant undertaking controls an ingredient, raw material, active substance, component, formulation input, or other indispensable production input and restricts competitors' access to it.

The concern is particularly serious where the undertaking:

• controls a scarce or unique ingredient;
• is vertically integrated into the downstream market;
• refuses to supply the ingredient to competing manufacturers;
• supplies it only on discriminatory or commercially unreasonable terms;
• imposes exclusive purchasing requirements;
• reserves the ingredient for its own downstream products;
• uses licensing or technology arrangements to restrict access;
• bundles the ingredient with another product or service; or
• deliberately reduces supplies to weaken downstream competitors.

The classic legal principle is that a dominant undertaking is not ordinarily required to supply competitors merely because they want to purchase from it. However, competition law may intervene where the ingredient is indispensable, alternatives are unavailable, refusal threatens to eliminate effective downstream competition, and there is no adequate objective justification.

The leading starting point is Commercial Solvents, where the Court of Justice held that a dominant supplier of a raw material could abuse its dominant position by refusing supplies to a downstream manufacturer while reserving the raw material for its own competing products.

2. Meaning of Ingredient Access Restrictions

An ingredient-access restriction may involve either complete denial or partial foreclosure.

A. Complete refusal

The dominant supplier simply stops selling an ingredient to an independent downstream manufacturer.

Example:
Company A controls 90% of the supply of a specialized pharmaceutical active ingredient. It begins producing its own competing medicine and refuses to supply the ingredient to competing drug manufacturers.

B. Selective supply

The dominant undertaking continues supplying some customers but excludes particular competitors.

C. Discriminatory supply

The ingredient is supplied to the dominant undertaking's own downstream subsidiary on favorable terms while competitors receive inferior terms.

D. Capacity restriction

The supplier deliberately reduces the quantity available to competitors even though adequate capacity exists.

E. Excessive or discriminatory pricing

Access is technically available but offered at a price that makes downstream competition commercially impossible.

F. Exclusivity

The supplier requires purchasers to obtain all or substantially all of their requirements from it, thereby preventing alternative suppliers from entering.

G. Technical or licensing restrictions

Access to an ingredient may depend upon proprietary technology, formulation rights, certification, patents, testing facilities, or know-how controlled by the dominant firm.

3. Relevant Competition-Law Framework

Ingredient-access restrictions can potentially fall under several theories.

A. Abuse of dominant position

Under the EU model, Article 102 TFEU prohibits abuse of a dominant position.

Comparable provisions exist in numerous jurisdictions, including:

• India — Section 4, Competition Act 2002
• China — Anti-Monopoly Law
• UK — Chapter II prohibition
• US — Section 2 Sherman Act, although US refusal-to-deal doctrine is generally narrower.

The central questions are:

1. Is the supplier dominant?
2. Is the ingredient a separate relevant market?
3. Is access to the ingredient commercially or technically indispensable?
4. Are there realistic substitutes?
5. Has supply actually been refused or restricted?
6. Does the conduct foreclose downstream competition?
7. Does the dominant firm compete downstream?
8. Is there an objective justification?
9. Are the restrictions proportionate to legitimate business objectives?

4. Relevant Market Analysis

The ingredient itself may constitute a separate product market.

For example:

Market 1: specialized pharmaceutical ingredient
↓
Market 2: medicines manufactured using that ingredient

or:

Market 1: proprietary industrial enzyme
↓
Market 2: processed food products

or:

Market 1: specialized semiconductor material
↓
Market 2: electronic devices.

The fact that the ingredient is used to produce another product does not prevent it from being treated as a distinct market.

In Commercial Solvents, the Court expressly recognized that a market for raw materials could be distinguished from the downstream market for products manufactured from those raw materials.

5. Essential-Facility / Indispensability Principle

Ingredient-access cases often overlap with the essential-facilities/refusal-to-deal doctrine.

The principal questions are:

1. Indispensability

Can competitors realistically obtain the ingredient elsewhere?

2. Duplication

Can competitors produce or source the ingredient themselves?

3. Competitive foreclosure

Would denial of access substantially eliminate or seriously weaken competition downstream?

4. Feasibility

Can the dominant supplier provide access without disproportionate technical, safety, capacity, or operational problems?

5. Objective justification

Is there a legitimate reason for refusing or restricting supply?

The European approach is particularly cautious. Bronner established a demanding standard for compulsory access, including indispensability, elimination of effective competition, and absence of objective justification.

6. At Least 6 Important Case Laws

1. Commercial Solvents Corp. v. Commission / Istituto Chemioterapico Italiano

Court: Court of Justice of the European Communities
Year: 1974

Facts

Commercial Solvents controlled the supply of certain chemical raw materials, including aminobutanol, which was required for manufacturing ethambutol.

The supplier began developing its own downstream products and restricted supplies to an independent manufacturer, Zoja.

Decision

The Court held that a dominant undertaking in a raw-material market could abuse its position where it refused to supply a downstream customer in circumstances that risked eliminating competition from that customer.

The Court emphasized that the raw-material market and downstream derivative market could be separately considered.

Principle

A dominant supplier cannot use control over an essential raw material to eliminate a downstream competitor while reserving the raw material for its own downstream operations.

Relevance

This is the most directly relevant authority for ingredient-access restrictions.

It establishes the classic vertical-foreclosure scenario:

Dominant ingredient supplier → downstream competitor → refusal → foreclosure.

2. United Brands v. Commission

Court: Court of Justice of the European Communities
Year: 1978

United Brands concerned the supply and distribution of bananas rather than a conventional ingredient.

The case is important because it established broader principles concerning dominance, discriminatory conditions, and restrictions imposed by a dominant undertaking.

Principle

A dominant undertaking has a special responsibility not to allow its conduct to distort effective competition.

The case is relevant where a dominant ingredient supplier imposes different conditions on customers without legitimate justification.

Application to ingredients

Suppose a dominant food-input supplier:

• supplies its own subsidiary at one price;
• supplies independent manufacturers at a substantially higher price;
• restricts volumes to competing manufacturers.

The United Brands principles can inform the assessment of discriminatory treatment and exclusionary effects.

3. Bronner v. Mediaprint

Court: Court of Justice of the European Communities
Year: 1998

Facts

Bronner sought access to an existing newspaper home-delivery system operated by competitors.

The Court rejected the claim because the facility was not sufficiently indispensable and alternatives could potentially be developed.

Importance for ingredient restrictions

Bronner establishes that mere commercial usefulness is insufficient.

For an ingredient-access claim, the complainant generally needs to demonstrate something substantially stronger:

• no realistic alternative ingredient;
• no reasonable alternative supplier;
• inability to reproduce the ingredient;
• significant technical barriers;
• significant economic barriers; and
• serious downstream competitive harm.

The doctrine therefore should not convert every supplier relationship into a compulsory-dealing obligation.

4. IMS Health v. Commission

Court: Court of Justice of the European Communities
Year: 2004

Facts

The dispute concerned access to a protected structure used for pharmaceutical-market data.

The case examined when refusal to license intellectual-property-related assets could constitute abuse.

Principle

The Court imposed stringent conditions before compulsory access could be required.

Among the relevant considerations were:

1. the input must be indispensable;
2. duplication must not be realistically possible;
3. refusal must eliminate effective competition; and
4. refusal must lack sufficient justification.

Relevance to ingredients

The principle is particularly relevant where an ingredient is connected with:

• patents;
• proprietary manufacturing processes;
• formulations;
• technical know-how;
• certification systems; or
• proprietary production technology.

A company cannot automatically avoid competition law scrutiny merely by placing an ingredient behind intellectual-property rights.

5. Aspen Skiing Co. v. Aspen Highlands Skiing Corp.

Court: US Supreme Court
Year: 1985

Facts

Aspen Skiing involved several ski resorts that had previously cooperated through a multi-area ticket arrangement.

The dominant operator subsequently terminated the arrangement and refused to continue dealing with the smaller competitor.

Decision

The Supreme Court found the conduct capable of constituting monopolization.

Relevance

The case is important for the concept of termination of a previously profitable course of dealing.

Applied to ingredients:

A competition concern becomes stronger where a dominant ingredient supplier:

• historically supplied the competitor;
• supplied the competitor profitably;
• suddenly terminates supply;
• continues supplying its own downstream operations; and
• lacks a legitimate business explanation.

However, US law treats refusal-to-deal cases cautiously, and Aspen Skiing should not be interpreted as creating a general duty to supply competitors.

6. MCI Communications Corp. v. AT&T

Court: US Court of Appeals, Seventh Circuit
Year: 1983

Principle

The case is a classic US essential-facilities authority.

The court identified factors concerning:

1. control of an essential facility by a monopolist;
2. inability of competitors reasonably to duplicate it;
3. denial of access;
4. feasibility of providing access.

These principles have subsequently been discussed extensively in US essential-facilities jurisprudence.

Application to ingredients

The framework can be applied where a company controls a uniquely necessary ingredient and:

• competitors cannot reasonably manufacture it;
• alternative suppliers do not exist;
• access is denied; and
• supplying the ingredient is technically feasible.

7. Slovak Telekom v. Commission

Court: Court of Justice of the European Union
Year: 2021

Although this case concerned telecommunications infrastructure rather than ingredients, it is highly relevant to modern access analysis.

The Court distinguished between situations where access is already required by regulation and situations where competition law is being used to create a duty to deal independently.

Relevance

The case illustrates an important principle:

competition-law access obligations can differ depending upon the regulatory framework governing the underlying facility or input.

Therefore, ingredient-access disputes involving regulated sectors—such as:

• pharmaceuticals;
• energy;
• food safety;
• chemicals;
• medical products;
• agricultural inputs—

may require analysis of both competition law and sector-specific access obligations.

7. Indian Competition-Law Perspective

In India, ingredient-access restrictions can principally be examined under Section 4 of the Competition Act, 2002, where the undertaking possesses a dominant position.

Potential forms of abuse include:

• limiting production or supply;
• denial of market access;
• discriminatory conditions;
• discriminatory pricing;
• leveraging dominance from one market into another;
• exclusionary contractual arrangements.

The Indian essential-facilities discussion is relevant by analogy.

Arshiya Rail Infrastructure Ltd. v. Ministry of Railways

The CCI considered whether infrastructure could constitute an essential facility and examined factors such as:

• technical feasibility of access;
• possibility of duplication;
• competitive harm from refusal;
• fair access terms.

Shamsher Kataria v. Honda Siel Cars India Ltd.

The CCI's analysis of access to automobile spare parts, diagnostic tools and repair information is particularly useful by analogy.

The case illustrates how competition concerns may arise when a manufacturer controls inputs necessary for downstream or complementary businesses.

Recent Indian commentary also identifies these cases as important developments in the application of essential-facility reasoning.

8. When Ingredient Restrictions Become Anti-Competitive

Not every refusal to supply is unlawful.

A useful analytical matrix is:

The strongest case generally exists where all or most of these factors converge.

9. Objective Justifications

A dominant supplier may have legitimate reasons for restricting access.

Examples include:

Safety

The ingredient may be dangerous or require controlled handling.

Quality control

The supplier may need to ensure that the ingredient is used according to technical specifications.

Capacity constraints

There may be genuine shortages or production limitations.

Regulatory requirements

Pharmaceutical, chemical, food, agricultural or environmental regulation may limit supply.

Intellectual property

The supplier may have legitimate IP rights, although IP ownership does not automatically immunize exclusionary conduct.

Credit risk

A supplier may legitimately restrict customers with serious payment-default problems.

Technical incompatibility

Supplying the ingredient may genuinely create safety or compatibility problems.

The critical question is whether the justification is genuine, proportionate and consistently applied, rather than a pretext for excluding competitors.

10. Discriminatory Ingredient Access

A particularly problematic scenario is:

Dominant supplier

↓

Own downstream subsidiary receives ingredient at favorable terms

↓

Independent competitors receive:

• higher prices;
• lower quantities;
• longer delivery periods;
• inferior quality;
• restrictive payment conditions.

This can create vertical foreclosure.

For example:

Supplier A controls 80% of a specialized enzyme market and manufactures finished food products through its subsidiary. The subsidiary receives the enzyme at ₹100/kg, while competing manufacturers are offered only ₹180/kg and subject to volume restrictions.

The competition-law question is not simply whether the prices differ. The analysis must examine:

• costs;
• market power;
• availability of alternatives;
• downstream margins;
• discriminatory rationale;
• actual or likely foreclosure.

11. Ingredient Bundling and Tying

Ingredient restrictions can also take the form of tying.

Example:

A dominant manufacturer supplies a critical pharmaceutical ingredient only if the customer also purchases:

• laboratory testing;
• packaging;
• machinery;
• software;
• logistics;
• another chemical ingredient.

This may create a tying concern where the dominant firm uses power in the ingredient market to expand into an adjacent market.

12. Exclusive Ingredient Purchasing

Another concern arises when a dominant supplier requires customers to purchase 100% of their ingredient requirements from it.

Such a provision can:

• prevent rival ingredient suppliers from entering;
• increase switching costs;
• foreclose competing suppliers;
• reinforce the incumbent's market power.

The assessment will depend upon:

• duration;
• percentage of demand covered;
• market coverage;
• alternatives;
• contractual penalties;
• customer bargaining power;
• market structure.

13. Refusal vs. Unreasonable Terms

Ingredient access does not necessarily have to be completely refused.

A dominant undertaking may effectively deny access through:

Direct refusal

"No supply will be provided."

Constructive refusal

Supply is technically offered but under commercially impossible conditions.

Excessive price

Price makes downstream production economically impossible.

Delayed supply

Delivery occurs too late for commercially viable production.

Quantity restriction

Only an insufficient amount is supplied.

Discriminatory quality

Competitors receive materially inferior inputs.

Unreasonable technical conditions

The conditions make access practically unusable.

Thus, access in form does not necessarily mean access in substance.

14. Competition Effects

Ingredient restrictions can produce several effects.

A. Foreclosure

Competitors cannot obtain the necessary input.

B. Higher downstream prices

Reduced competition may allow downstream prices to increase.

C. Reduced output

Competitors may reduce production because of inadequate ingredient supplies.

D. Reduced innovation

New entrants may be unable to develop competing products.

E. Increased concentration

Competitors may exit, leaving the dominant undertaking with greater downstream market power.

F. Entry deterrence

Potential entrants may conclude that obtaining the necessary ingredient is impossible.

15. Difference Between Legitimate Vertical Integration and Abuse

Vertical integration itself is not prohibited.

A company may legitimately:

• manufacture its own ingredients;
• use its ingredients internally;
• develop proprietary formulations;
• enter downstream markets;
• choose its commercial partners.

The competition concern arises when market power over the ingredient is used strategically to exclude or weaken downstream competition.

This distinction is central to Commercial Solvents: the problem was not simply that the undertaking entered the downstream market, but that it controlled the raw material and used that position to restrict a downstream competitor's access.

16. Hub-and-Spoke / Distributor Dimension

Ingredient restrictions can also arise indirectly.

For example:

Ingredient manufacturer
↓
Distributor network
↓
Downstream manufacturers

If the dominant manufacturer uses distributors to:

• identify competing purchasers;
• coordinate allocation;
• restrict supply;
• impose common resale conditions;
• exchange commercially sensitive information;

the conduct may raise additional concerns involving information exchange, vertical restraints, or coordinated conduct.

17. Economic Assessment

Authorities generally need to distinguish genuine exclusion from ordinary commercial competition.

Important economic evidence includes:

Market shares

How much of the relevant ingredient market does the supplier control?

HHI and concentration

How concentrated is the ingredient market?

Import availability

Can the ingredient realistically be imported?

Switching costs

How expensive is it for purchasers to change suppliers?

Product substitutability

Can another ingredient perform the same function?

Entry barriers

Can a new ingredient producer enter?

Downstream foreclosure

What percentage of downstream demand is affected?

Duration

How long has the restriction existed?

18. Practical Hypothetical

Assume:

Alpha Chemicals

• controls 85% of a specialized food additive;
• supplies the additive to independent food manufacturers;
• subsequently launches its own competing food brand;
• stops supplying three major competitors;
• continues supplying its own subsidiary;
• claims that its production capacity is limited.

A competition authority would examine:

1. whether the additive is a separate relevant market;
2. whether Alpha is dominant;
3. whether alternative additives exist;
4. whether alternative suppliers can enter;
5. whether competitors can manufacture the additive themselves;
6. whether Alpha actually has a capacity shortage;
7. whether its own subsidiary receives preferential quantities;
8. whether the refusal threatens downstream competition;
9. whether the restriction is objectively justified;
10. whether less restrictive supply arrangements were possible.

If the evidence demonstrates that Alpha deliberately reserved a scarce ingredient for its own competing downstream products while excluding independent manufacturers, the facts would closely resemble the logic of Commercial Solvents.

19. Key Case-Law Principles Compared

20. Compliance Checklist for Businesses

A dominant ingredient supplier should carefully review:

• whether the ingredient constitutes a separate market;
• its market share and market power;
• availability of substitutes;
• reasons for refusing supply;
• whether the refusal is applied consistently;
• whether its own downstream business receives preferential treatment;
• whether competitors were previously supplied;
• whether supply termination followed downstream entry;
• whether quantity restrictions are objectively justified;
• whether technical requirements are proportionate;
• whether exclusivity provisions are necessary;
• whether customers have realistic alternative suppliers.

All internal documentation concerning supply restrictions should accurately record the legitimate commercial rationale, particularly where the supplier also competes downstream.

21. Conclusion

Ingredient Access Restrictions become a significant competition-law issue when control over a critical input is used to restrict competition in a downstream market.

The central authority is Commercial Solvents, which established that a dominant undertaking controlling a raw material may abuse its position when it refuses supplies to a downstream competitor in order to reserve the raw material for its own competing products.

The modern analysis, however, is more demanding than simply asking whether an ingredient is important. Authorities generally examine dominance, indispensability, availability of substitutes, duplication possibilities, foreclosure, discriminatory treatment, objective justification, proportionality, and the actual competitive effects.

Accordingly, the strongest ingredient-access cases generally involve the combination of:

Dominant input supplier + indispensable ingredient + downstream competition + refusal/restriction + absence of adequate alternatives + substantial foreclosure + lack of objective justification.